Menu
GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
    • HTA Philippines Social Values Guide
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • HTA Philippines Annual Report
      • 2021 HTA Annual Report
      • 2020 HTA Annual Report
      • 2019 HTA Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Assessments
  • Issuances
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Careers
    • Contact Us
    • Call for Nomination
    • Topic Nomination
  • AUXILIARY MENU
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
    • HTA Philippines Social Values Guide
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • HTA Philippines Annual Report
      • 2021 HTA Annual Report
      • 2020 HTA Annual Report
      • 2019 HTA Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Assessments
  • Issuances
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Careers
    • Contact Us
    • Call for Nomination
    • Topic Nomination

News brief

nimble_asset_Website-banner-Assessments

HTA Philippines Guidance: Efforts to Facilitate the HTA Transfer

nimble_asset_Website-banner-Assessments

HTAC GUIDANCE: PNF INCLUSION OF RECOMBINANT HUMAN ERYTHROPOIETIN (EPOETIN ALFA) 4000 IU/ML SOLUTION FOR INJECTION (IV/SC) 1ML PRE-FILLED SYRINGE

nimble_asset_Website-banner-Assessments

HTAC GUIDANCE: PNF INCLUSION OF FILGRASTIM 300 MCG/0.9 ML SOLUTION (IV, SC), 0.9 ML PRE-FILLED SYRINGE

[ANNOUNCEMENT] CEREMONIAL TURNOVER OF HTA IMPLEMENTATION FROM THE DEPARTMENT OF HEALTH TO THE DEPARTMENT OF SCIENCE AND TECHNOLOGY

nimble_asset_Website-banner-Assessments

[ANNOUNCEMENT] HTA COUNCIL RELEASES ITS PRELIMINARY RECOMMENDATION ON THE FINANCING OF DAPAGLIFLOZIN FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS

nimble_asset_Website-banner-Assessments

[ANNOUNCEMENT] HTAC RELEASES ITS ADVISORY ON THE ANNOUNCEMENT FOR THE CALL FOR NOMINATIONS FOR THE GENERAL TRACK ASSESSMENT FOR 2024

HTAC recommendation on Moderna COVID-19 Vaccine for children 6 to 11 years old

HTAC recommendation on Moderna COVID-19 Vaccine for children 6 to 11 years old

Evidence Summary on AstraZeneca COVID-19 vaccine as Second Booster/ Fourth Dose for the prevention of COVID-19

DOST Visit to the HTA Philippines Office

Post navigation

← Older posts
827853
Users Today : 476
This Month : 12334
Total Users : 827853
Your IP Address : 3.238.253.163
Philippine Standard Time:
✕

Philippine Society of Microbiology and Infectious Diseases (PSMID) releases Philippine COVID-19 Living Recommendations

View the document on their website: https://www.psmid.org/philippine-covid-19-living-recommendations/